Selected research
Industry Research
Molecular Pathology Services Industry Research Report 2026
Market perspective
The global Molecular Pathology Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Molecular Pathology Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Molecular Pathology Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Molecular Pathology Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Molecular Pathology Services include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health and Exact Sciences, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Molecular Pathology Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Molecular Pathology Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Molecular Pathology Services Market by Company
Quest Diagnostics
Labcorp
Sonic Healthcare
NeoGenomics
Foundation Medicine
Caris Life Sciences
Tempus
Guardant Health
Exact Sciences
Eurofins
Unilabs
Molecular Pathology Services Segment by Type
Solid Tumor Molecular Pathology Services
Hematologic Malignancy Molecular Pathology Services
Hereditary Disease Molecular Pathology Services
Infectious Disease Molecular Testing Services
Rare Disease Molecular Pathology Services
Others
Molecular Pathology Services Segment by Application
Hospitals and Medical Centers
Independent Clinical Laboratories
Academic and Research Institutes
Biopharmaceutical Companies
Others
Molecular Pathology Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Pathology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Pathology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Pathology Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Molecular Pathology Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Tumor Molecular Pathology Services
- Hematologic Malignancy Molecular Pathology Services
- Hereditary Disease Molecular Pathology Services
- Infectious Disease Molecular Testing Services
- Rare Disease Molecular Pathology Services
- Others
Applications
- Hospitals and Medical Centers
- Independent Clinical Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Others
Companies covered
- Quest Diagnostics
- Labcorp
- Sonic Healthcare
- NeoGenomics
- Foundation Medicine
- Caris Life Sciences
- Tempus
- Guardant Health
- Exact Sciences
- Eurofins
- Unilabs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Molecular Pathology Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Solid Tumor Molecular Pathology Services
- 2.2.3 Hematologic Malignancy Molecular Pathology Services
- 2.2.4 Hereditary Disease Molecular Pathology Services
- 2.2.5 Infectious Disease Molecular Testing Services
- 2.2.6 Rare Disease Molecular Pathology Services
- 2.2.7 Others
- 2.3 Molecular Pathology Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals and Medical Centers
- 2.3.3 Independent Clinical Laboratories
- 2.3.4 Academic and Research Institutes
- 2.3.5 Biopharmaceutical Companies
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Molecular Pathology Services Breakdown Data by Type
- 3.1 Global Molecular Pathology Services Historic Market Size by Type (2021-2026)
- 3.2 Global Molecular Pathology Services Forecasted Market Size by Type (2027-2032)
4 Molecular Pathology Services Breakdown Data by Application
- 4.1 Global Molecular Pathology Services Historic Market Size by Application (2021-2026)
- 4.2 Global Molecular Pathology Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Molecular Pathology Services Market Perspective (2021-2032)
- 5.2 Global Molecular Pathology Services Growth Trends by Region
- 5.2.1 Global Molecular Pathology Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Molecular Pathology Services Historic Market Size by Region (2021-2026)
- 5.2.3 Molecular Pathology Services Forecasted Market Size by Region (2027-2032)
- 5.3 Molecular Pathology Services Market Dynamics
- 5.3.1 Molecular Pathology Services Industry Trends
- 5.3.2 Molecular Pathology Services Market Drivers
- 5.3.3 Molecular Pathology Services Market Challenges
- 5.3.4 Molecular Pathology Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Molecular Pathology Services Players by Revenue
- 6.1.1 Global Top Molecular Pathology Services Players by Revenue (2021-2026)
- 6.1.2 Global Molecular Pathology Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Molecular Pathology Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Molecular Pathology Services Head Office and Area Served
- 6.4 Global Molecular Pathology Services Players, Product Type & Application
- 6.5 Global Molecular Pathology Services Manufacturers Established Date
- 6.6 Global Molecular Pathology Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Molecular Pathology Services Market Size (2021-2032)
- 7.2 North America Molecular Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Molecular Pathology Services Market Size by Country (2021-2026)
- 7.4 North America Molecular Pathology Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Molecular Pathology Services Market Size (2021-2032)
- 8.2 Europe Molecular Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Molecular Pathology Services Market Size by Country (2021-2026)
- 8.4 Europe Molecular Pathology Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Molecular Pathology Services Market Size (2021-2032)
- 9.2 Asia-Pacific Molecular Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Molecular Pathology Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Molecular Pathology Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Molecular Pathology Services Market Size (2021-2032)
- 10.2 South America Molecular Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Molecular Pathology Services Market Size by Country (2021-2026)
- 10.4 South America Molecular Pathology Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Molecular Pathology Services Market Size (2021-2032)
- 11.2 Middle East & Africa Molecular Pathology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Molecular Pathology Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Molecular Pathology Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Quest Diagnostics
- 12.1.1 Quest Diagnostics Company Information
- 12.1.2 Quest Diagnostics Business Overview
- 12.1.3 Quest Diagnostics Revenue in Molecular Pathology Services Business (2021-2026)
- 12.1.4 Quest Diagnostics Molecular Pathology Services Product Portfolio
- 12.1.5 Quest Diagnostics Recent Developments
- 12.2 Labcorp
- 12.2.1 Labcorp Company Information
- 12.2.2 Labcorp Business Overview
- 12.2.3 Labcorp Revenue in Molecular Pathology Services Business (2021-2026)
- 12.2.4 Labcorp Molecular Pathology Services Product Portfolio
- 12.2.5 Labcorp Recent Developments
- 12.3 Sonic Healthcare
- 12.3.1 Sonic Healthcare Company Information
- 12.3.2 Sonic Healthcare Business Overview
- 12.3.3 Sonic Healthcare Revenue in Molecular Pathology Services Business (2021-2026)
- 12.3.4 Sonic Healthcare Molecular Pathology Services Product Portfolio
- 12.3.5 Sonic Healthcare Recent Developments
- 12.4 NeoGenomics
- 12.4.1 NeoGenomics Company Information
- 12.4.2 NeoGenomics Business Overview
- 12.4.3 NeoGenomics Revenue in Molecular Pathology Services Business (2021-2026)
- 12.4.4 NeoGenomics Molecular Pathology Services Product Portfolio
- 12.4.5 NeoGenomics Recent Developments
- 12.5 Foundation Medicine
- 12.5.1 Foundation Medicine Company Information
- 12.5.2 Foundation Medicine Business Overview
- 12.5.3 Foundation Medicine Revenue in Molecular Pathology Services Business (2021-2026)
- 12.5.4 Foundation Medicine Molecular Pathology Services Product Portfolio
- 12.5.5 Foundation Medicine Recent Developments
- 12.6 Caris Life Sciences
- 12.6.1 Caris Life Sciences Company Information
- 12.6.2 Caris Life Sciences Business Overview
- 12.6.3 Caris Life Sciences Revenue in Molecular Pathology Services Business (2021-2026)
- 12.6.4 Caris Life Sciences Molecular Pathology Services Product Portfolio
- 12.6.5 Caris Life Sciences Recent Developments
- 12.7 Tempus
- 12.7.1 Tempus Company Information
- 12.7.2 Tempus Business Overview
- 12.7.3 Tempus Revenue in Molecular Pathology Services Business (2021-2026)
- 12.7.4 Tempus Molecular Pathology Services Product Portfolio
- 12.7.5 Tempus Recent Developments
- 12.8 Guardant Health
- 12.8.1 Guardant Health Company Information
- 12.8.2 Guardant Health Business Overview
- 12.8.3 Guardant Health Revenue in Molecular Pathology Services Business (2021-2026)
- 12.8.4 Guardant Health Molecular Pathology Services Product Portfolio
- 12.8.5 Guardant Health Recent Developments
- 12.9 Exact Sciences
- 12.9.1 Exact Sciences Company Information
- 12.9.2 Exact Sciences Business Overview
- 12.9.3 Exact Sciences Revenue in Molecular Pathology Services Business (2021-2026)
- 12.9.4 Exact Sciences Molecular Pathology Services Product Portfolio
- 12.9.5 Exact Sciences Recent Developments
- 12.10 Eurofins
- 12.10.1 Eurofins Company Information
- 12.10.2 Eurofins Business Overview
- 12.10.3 Eurofins Revenue in Molecular Pathology Services Business (2021-2026)
- 12.10.4 Eurofins Molecular Pathology Services Product Portfolio
- 12.10.5 Eurofins Recent Developments
- 12.11 Unilabs
- 12.11.1 Unilabs Company Information
- 12.11.2 Unilabs Business Overview
- 12.11.3 Unilabs Revenue in Molecular Pathology Services Business (2021-2026)
- 12.11.4 Unilabs Molecular Pathology Services Product Portfolio
- 12.11.5 Unilabs Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst